“It’s like you’ve named your new form of research ‘the best ever.'” — Vesta Silva, PhD, of Allegheny College in Meadville, Pennsylvania, discussing the Trump administration’s emphasis on “gold standard science.”
“As in many things in life, it is way more complicated than people are making [it] out to be.” — Peter P. Lee, MD, of City of Hope Comprehensive Cancer Center near Los Angeles, on using ivermectin to treat cancer.
“We have people who are asking questions of the CDC like it’s a college epidemiology class, not understanding basic principles.” — James Lawler, MD, MPH, of the University of Nebraska Medical Center’s Global Center for Health Security in Omaha, on the recent meeting of CDC’s new Advisory Committee on Immunization Practices.
“He was a true giant.” — Robert Wachter, MD, of the University of California San Francisco, discussing the death of Lucian Leape, MD, the father of the patient safety movement.
“We are proud of our track record in communicating U.S. research to the rest of the world for over a century.” — A spokesperson for Springer Nature, after the Trump administration terminated contracts with the publishing giant.
“A key to resilience among centenarians is that although amyloid and tau may be present, they are present at a lower, more manageable level that is less likely to cause cognitive impairment.” — Stacy Andersen, PhD, of Boston University, on amyloid-beta accumulation in people who live to be 100 and beyond.